CIK 0001813814 · Medicinal Chemicals & Botanical Products (SIC 2833) · Nasdaq · incorporated in A1 · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -183.8 M | -95.7 M | -56.8 M |
| Diluted EPS (USD/shares) | -2.06 | -2.44 | -1.84 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-29 | 4 | OWNERSHIP DOCUMENT | 2026-09-25 |
| 2026-09-29 | 4 | OWNERSHIP DOCUMENT | 2026-09-25 |
| 2026-09-29 | 4 | OWNERSHIP DOCUMENT | 2026-09-25 |
| 2026-09-29 | 4 | OWNERSHIP DOCUMENT | 2026-09-25 |
| 2026-09-29 | 4 | OWNERSHIP DOCUMENT | 2026-09-25 |
| 2026-09-25 | 144 | 144 | |
| 2026-09-25 | 144 | 144 | |
| 2026-09-25 | 144 | 144 | |
| 2026-09-25 | 144 | 144 | |
| 2026-09-25 | 144 | 144 | |
| 2026-09-18 | 4 | 4 | 2026-09-18 |
| 2026-09-18 | 4 | 4 | 2026-09-18 |
| 2026-09-14 | 4 | 4 | 2026-09-14 |
| 2026-09-14 | 4 | 4 | 2026-09-14 |
| 2026-09-14 | 4 | 4 | 2026-09-14 |
| 2026-09-14 | 4 | 4 | 2026-09-14 |
| 2026-09-14 | 4 | 4 | 2026-09-14 |
| 2026-09-14 | 8-K | FORM 8-K items 7.01,8.01,9.01 | 2026-09-14 |
| 2026-09-08 | 8-K | 8-K items 8.01,9.01 | 2026-09-08 |
| 2026-09-04 | 4 | 4 | 2026-09-02 |
| 2026-09-03 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 4 | 4 | 2026-08-12 |
| 2026-08-12 | 4 | 4 | 2026-08-12 |
Forms on file (last 1,000): 4 160, 8-K 78, 144 48, 6-K 46, DEFA14A 30, 3 18, DFAN14A 17, 10-Q 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=DFTX (0.002 USD), /gw/filings/filings?ticker=DFTX&form=8-K, /gw/filings/facts?ticker=DFTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange